"The
Report Birch Pollen Allergy - Pipeline Review, H2 2016 provides
information on pricing, market analysis, shares, forecast, and
company profiles for key industry participants. -
MarketResearchReports.biz"
Global Markets Directs,
Birch Pollen Allergy -
Pipeline Review, H2 2016, provides an overview of the Birch Pollen
Allergy pipeline landscape.
The report provides
comprehensive information on the therapeutics under development for
Birch Pollen Allergy, complete with analysis by stage of development,
drug target, mechanism of action (MoA), route of administration (RoA)
and molecule type. The report also covers the descriptive
pharmacological action of the therapeutics, its complete research and
development history and latest news and press releases. Additionally,
the report provides an overview of key players involved in
therapeutic development for Birch Pollen Allergy and features dormant
and discontinued projects.
Global Markets Directs report
features investigational drugs from across globe covering over 20
therapy areas and nearly 3,000 indications. The report is built using
data and information sourced from Global Markets Directs proprietary
databases, company/university websites, clinical trial registries,
conferences, SEC filings, investor presentations and featured press
releases from company/university sites and industry-specific third
party sources. Drug profiles featured in the report undergoes
periodic review following a stringent set of processes to ensure that
all the profiles are updated with the latest set of information.
Additionally, various dynamic tracking processes ensure that the most
recent developments are captured on a real time basis.
The report helps in identifying
and tracking emerging players in the market and their portfolios,
enhances decision making capabilities and helps to create effective
counter strategies to gain competitive advantage.
Download
Sample copy of this Report at:
http://www.marketresearchreports.biz/sample/sample/794413
Scope
-
The report provides a snapshot of the global therapeutic landscape of
Birch Pollen Allergy
-
The report reviews pipeline therapeutics for Birch Pollen Allergy by
companies and universities/research institutes based on information
derived from company and industry-specific sources
-
The report covers pipeline products based on various stages of
development ranging from pre-registration till discovery and
undisclosed stages
-
The report features descriptive drug profiles for the pipeline
products which includes, product description, descriptive MoA, R&D
brief, licensing and collaboration details & other developmental
activities
-
The report reviews key players involved Birch Pollen Allergy
therapeutics and enlists all their major and minor projects
-
The report assesses Birch Pollen Allergy therapeutics based on drug
target, mechanism of action (MoA), route of administration (RoA) and
molecule type
-
The report summarizes all the dormant and discontinued pipeline
projects
-
The report reviews latest news related to pipeline therapeutics for
Birch Pollen Allergy
Reasons
to buy
-
Gain strategically significant competitor information, analysis, and
insights to formulate effective R&D strategies
-
Identify emerging players with potentially strong product portfolio
and create effective counter-strategies to gain competitive advantage
-
Identify and understand important and diverse types of therapeutics
under development for Birch Pollen Allergy
-
Identify potential new clients or partners in the target demographic
-
Develop strategic initiatives by understanding the focus areas of
leading companies
-
Plan mergers and acquisitions effectively by identifying key players
and its most promising pipeline therapeutics
-
Devise corrective measures for pipeline projects by understanding
Birch Pollen Allergy pipeline depth and focus of Indication
therapeutics
-
Develop and design in-licensing and out-licensing strategies by
identifying prospective partners with the most attractive projects to
enhance and expand business potential and scope
-
Modify the therapeutic portfolio by identifying discontinued projects
and understanding the factors that drove them from pipeline
Table
Of Content
Table
of Contents 2
List
of Tables 4
List
of Figures 4
Introduction
5
Global
Markets Direct Report Coverage 5
Birch
Pollen Allergy Overview 6
Therapeutics
Development 7
Pipeline
Products for Birch Pollen Allergy - Overview 7
Birch
Pollen Allergy - Therapeutics under Development by Companies 8
Birch
Pollen Allergy - Pipeline Products Glance 9
Late
Stage Products 9
Clinical
Stage Products 10
Early
Stage Products 11
Birch
Pollen Allergy - Products under Development by Companies 12
Birch
Pollen Allergy - Companies Involved in Therapeutics Development 13
ALK-Abello
A/S 13
Allergopharma
GmbH & Co. KG 14
Anergis
SA 15
Biomay
AG 16
Circassia
Pharmaceuticals Plc 17
HAL
Allergy BV 18
Stallergenes
SAS 19
Birch
Pollen Allergy - Therapeutics Assessment 20
Assessment
by Monotherapy Products 20
Assessment
by Target 21
Assessment
by Route of Administration 22
Assessment
by Molecule Type 24
Drug
Profiles 26
Allergen
for Birch Pollen Induced Allergic Rhinitis and Rhinoconjunctivitis -
Drug Profile 26
Product
Description 26
Mechanism
Of Action 26
R&D
Progress 26
Allergen
for Birch Pollen Induced Allergic Rhinoconjunctivitis - Drug Profile
27
Product
Description 27
Mechanism
Of Action 27
R&D
Progress 27
AllerT
- Drug Profile 28
Product
Description 28
Mechanism
Of Action 28
R&D
Progress 28
Birch
Pollen Allergoid - Drug Profile 32
Product
Description 32
Follow
us on LinkedIn:
https://www.linkedin.com/company/marketresearchreports-biz
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment